These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10896116)

  • 1. 6-Substituted 2,2-bis(fluoromethyl)-benzopyran-4-carboxamide K+ channel openers.
    Taka N; Koga H; Sato H; Ishizawa T; Takahashi T; Imagawa J
    Bioorg Med Chem; 2000 Jun; 8(6):1393-405. PubMed ID: 10896116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat.
    Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH
    J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
    Lee YM; Peng YY; Sheu JR; Cheng CY; Yen MH
    Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of SKP-450, a new potassium-channel activator.
    Lee BH; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs.
    Kusumoto K; Awane Y; Kitayoshi T; Fujiwara S; Hashiguchi S; Terashita Z; Shiraishi M; Watanabe T
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):929-36. PubMed ID: 7898076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel potassium channel opener prodrugs with a slow onset and prolonged duration of action.
    Horino H; Mimura T; Kobayashi S; Ohta M; Kubo H; Ito K; Tsumura M; Kitagawa M
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):490-5. PubMed ID: 10783067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Heterocyclyloxy-2H-1-benzopyran potassium channel activators.
    Bergmann R; Eiermann V; Gericke R
    J Med Chem; 1990 Oct; 33(10):2759-67. PubMed ID: 2213828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.
    Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
    Bergmann R; Gericke R
    J Med Chem; 1990 Feb; 33(2):492-504. PubMed ID: 2299619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.